Literature DB >> 26346046

Liver dysfunction in patients with severe anorexia nervosa.

Elissa Rosen1,2,3, Allison L Sabel4,5, John T Brinton1,2,3, Brittany Catanach1,2, Jennifer L Gaudiani1,2,3, Philip S Mehler1,2,3,6.   

Abstract

OBJECTIVE: Evaluation of liver dysfunction in patients with severe anorexia nervosa (AN) has typically been limited to small case series. We report an investigation into the admission characteristics and clinical outcomes associated with liver dysfunction in a large cohort of adults hospitalized for medical stabilization of severe AN.
METHODS: We retrospectively evaluated electronic medical records to quantify the cumulative incidence of elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT). We compared mean (±SD), frequencies (%), and median (IQR) values of clinical covariates of interest by incidence of liver enzyme elevation. The study included 181 adults, admitted for medical stabilization of AN, from October 1, 2008 to December 31, 2013.
RESULTS: AST and ALT were mildly elevated in 27.6% of patients and severely elevated (more than three times the upper limit of normal) in 35.4% of patients. On admission, patients with severely elevated liver enzymes had a lower body mass index (BMI) (11.9 ± 1.8 kg/m(2) vs.13.3 ± 1.7 kg/m(2)), lower percentage ideal body weight (56.5% ± 7.7% vs. 63.5% ± 8.3%), and lower prealbumin (64% vs. 37%) compared with the rest of the cohort (p < 0.001). While hospitalized, patients with severely elevated liver enzymes more often developed hypoglycemia, hypophosphatemia, and experienced longer lengths of stay (p < 0.001). DISCUSSION: Elevated liver enzymes are common in our patient population with severe AN. Liver enzymes reached near normal values by the time of discharge. Severely elevated liver enzymes were associated with a lower BMI and the development of hypoglycemia.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  aminotransferases; anorexia nervosa; eating disorder; liver dysfunction; liver enzymes; liver function tests

Mesh:

Substances:

Year:  2015        PMID: 26346046     DOI: 10.1002/eat.22436

Source DB:  PubMed          Journal:  Int J Eat Disord        ISSN: 0276-3478            Impact factor:   4.861


  17 in total

1.  Common and Emergent Oral and Gastrointestinal Manifestations of Eating Disorders.

Authors:  Jessica A Lin; Elizabeth R Woods; Elana M Bern
Journal:  Gastroenterol Hepatol (N Y)       Date:  2021-04

2.  Expanding the differential diagnosis for transaminitis in patients with anorexia nervosa.

Authors:  Adam C Nadelson; Victor D Babatunde; Eric U Yee; Vilas R Patwardhan
Journal:  J Gen Intern Med       Date:  2017-04       Impact factor: 5.128

Review 3.  Hepatic Complications of Anorexia Nervosa.

Authors:  Elissa Rosen; Neeru Bakshi; Ashlie Watters; Hugo R Rosen; Philip S Mehler
Journal:  Dig Dis Sci       Date:  2017-09-20       Impact factor: 3.199

4.  Monitoring and treating hypoglycemia during meal-based rapid nutritional rehabilitation in patients with extreme anorexia nervosa.

Authors:  Laura K Fischer; Colleen C Schreyer; Allisyn Pletch; Marita Cooper; Irina A Vanzhula; Graham W Redgrave; Angela S Guarda
Journal:  Eat Weight Disord       Date:  2022-08-22       Impact factor: 3.008

5.  Anorexia nervosa and the gastrointestinal tract.

Authors:  Wisam Jafar; James Morgan
Journal:  Frontline Gastroenterol       Date:  2021-08-20

6.  Liver Damage Is Related to the Degree of Being Underweight in Anorexia Nervosa and Improves Rapidly with Weight Gain.

Authors:  Ulrich Cuntz; Ulrich Voderholzer
Journal:  Nutrients       Date:  2022-06-08       Impact factor: 6.706

7.  Risk factors for elevated liver enzymes during refeeding of severely malnourished patients with eating disorders: a retrospective cohort study.

Authors:  Miho Imaeda; Satoshi Tanaka; Hiroshige Fujishiro; Saki Kato; Masatoshi Ishigami; Naoko Kawano; Hiroto Katayama; Kunihiro Kohmura; Masahiko Ando; Kazuo Nishioka; Norio Ozaki
Journal:  J Eat Disord       Date:  2016-12-07

8.  Microbiota in anorexia nervosa: The triangle between bacterial species, metabolites and psychological tests.

Authors:  Francesca Borgo; Alessandra Riva; Alberto Benetti; Maria Cristina Casiraghi; Sara Bertelli; Stefania Garbossa; Simona Anselmetti; Silvio Scarone; Antonio E Pontiroli; Giulia Morace; Elisa Borghi
Journal:  PLoS One       Date:  2017-06-21       Impact factor: 3.240

9.  Extreme anorexia nervosa: medical findings, outcomes, and inferences from a retrospective cohort.

Authors:  Dennis Gibson; Ashlie Watters; Jeana Cost; Margherita Mascolo; Philip S Mehler
Journal:  J Eat Disord       Date:  2020-06-23

10.  Non-alcoholic fatty liver disease in underweight patients with inflammatory bowel disease: A case-control study.

Authors:  Lisa C Adams; Falk Lübbe; Keno Bressem; Moritz Wagner; Bernd Hamm; Marcus R Makowski
Journal:  PLoS One       Date:  2018-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.